Last update 21 Nov 2024

Imidacrine

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Imidazoloacridine, Symadex, Symadex Pathfinder
+ [6]
Mechanism
FLT3 inhibitors(Tyrosine-protein kinase receptor FLT3 inhibitors), TOP1 inhibitors(DNA topoisomerase I inhibitors), Top II inhibitors(Topoisomerase II inhibitors)
Active Indication-
Originator Organization
Active Organization-
Drug Highest PhaseDiscontinuedPhase 2
First Approval Date-
Regulation-
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Breast CancerPhase 2--
Breast CancerPhase 2--
Breast CancerPhase 2--
Breast CancerPhase 2--
Colitis, UlcerativePhase 2
US
-
Colorectal CancerPhase 2--
Colorectal CancerPhase 2
GB
-
Colorectal CancerPhase 2--
Colorectal CancerPhase 2--
Rheumatoid ArthritisPhase 2
US
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
36
(sgknyyxuiw) = dvsugsphvc mhluvfquna (sxdimrilit )
-
20 May 2008
Phase 2
53
meukyetidm(amiyhywxnj) = aimsxmbyjj hjiezlnsqy (sbaouelnzm )
-
20 May 2008
Phase 1
16
(cejdhxvaui) = Grade 1 or 2 AEs most commonly reported as drug-related were nausea, asthenia, vomiting and diarrhea. pcslnqwalf (rpuijglauc )
-
20 Jun 2006
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free